Skip to main content

Anti-Rheumatic Rx

      The RheumNow faculty have parked at the plenaries, trafficked the posters and have been finding the best the meeting offers on the first day at ACR 2024 in Washington, DC.  Here are some of the…
      New data to guide role of long-term, low dose GC in GPA

      Active GPA s/p tx -> randomized to d/c pred within 1 mo or s
      1 month 1 week ago
      New data to guide role of long-term, low dose GC in GPA Active GPA s/p tx -> randomized to d/c pred within 1 mo or stay on 5mg daily Fewer relapses on 5mg pred but w/qualifications: 👉 most flares = minor 👉 no difference in flares if RTX on board @RheumNow #ACR24 Abst 0774 https://t.co/Jvc40QWLqM
      Coming from somewhere where biosimilars are SOC for many years, I just find it wild how things are biosimilar wise in th
      1 month 1 week ago
      Coming from somewhere where biosimilars are SOC for many years, I just find it wild how things are biosimilar wise in the US. Reflected by so many abstracts, including lots of oral presentations, essentially on showing biosimilars work. #ACR24 @RheumNow
      Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing back pain, stiffness, and reduced mobility. The disease includes both…
      Abstract #0805
      Data from OTIS Registry shows Certolizumab pegol (Cimzia) exposure during pregnancy was not associated wi
      1 month 1 week ago
      Abstract #0805 Data from OTIS Registry shows Certolizumab pegol (Cimzia) exposure during pregnancy was not associated with increased risk of major birth defects, structural defects, or adverse pregnancy outcomes. #ACR24 @RheumNow
      What's the assoc between RA disease activity & ILD?

      Results @MassGenBrigham show early active RA is assoc with
      ➡?
      1 month 1 week ago
      What's the assoc between RA disease activity & ILD? Results @MassGenBrigham show early active RA is assoc with ➡️6x incr risk of #ILD ➡️4x incr risk of RA-related lung disease Early DMARDs are vital to reduce articular & extra-articular manifestations! Ab0802 #ACR24 @RheumNow
      ❔Can rheum drugs have beneficial effects on cognition?

      💊Possible benefits with MTX and TNFis but certainly an acti
      1 month 1 week ago
      ❔Can rheum drugs have beneficial effects on cognition? 💊Possible benefits with MTX and TNFis but certainly an active area of research and more studies needed #ACR24 @RheumNow https://t.co/lCnIRLwNjK
      Ab#0458 #ACR24
      10 year outcomes of 176 patients with seroneg RA
      32 pts (18%) had change in dx - SpA (11), seropos RA (6)
      1 month 1 week ago
      Ab#0458 #ACR24 10 year outcomes of 176 patients with seroneg RA 32 pts (18%) had change in dx - SpA (11), seropos RA (6), OA (5), crystal (3), CTD (3), Ifn-related/paraneopl/RS3PE, sarcoid (1) 40 (23%) had drug-free remission 30 (17%) started b/tsDMARD @RheumNow
      ×